The ETV6::ABL1 fusion was recently included in the genetic abnormalities defining the disease category of myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) [1, 2]. This evidence concerns the gene ABL1 and lymphoid neoplasm.